Announcements Trials
Browse Landscape

Phase

Phase 2 145Phase 1 98Phase NA 83Phase 1/2 61Phase 3 21Phase EARLY_PHASE1 7Phase 2/3 3Phase 4 2

Status

Completed 9Unknown 6Terminated 5Active not recruiting 4Recruiting 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 75Other hematologic neoplasm 32Lymphoid 27Genitourinary 27Gynecologic 25Thoracic 23Head & Neck 20Breast 17Plasma cell 9Dermatologic 9CNS 8Tumor-Agnostic 5Myeloid 5Endocrine 5Other 4Sarcoma 3Other solid neoplasm 3NET 3Classical hematology 3

Conditions

Stomach Neoplasms 1Sarcoma 1Ovarian Carcinosarcoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Hematologic Neoplasms 1Glioma 1

Interventions

niraparib 1merphos 1dostarlimab 1capmatinib 1cabozantinib 1X-Rays 1Surgical Procedures, Operative 1Platinum 1Phantoms, Imaging 1Methotrexate 1Magnetic Resonance Spectroscopy 1Doxorubicin 1Cisplatin 1Antineoplastic Agents 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Sarcoma × Clear all
NCT05691478 2026-05-27

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting
138 enrolled
GynecologicSarcoma

Ovarian Carcinosarcoma

NCT06988475 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSGastrointestinalOther hematologic neoplasmSarcoma

Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Sarcoma, Stomach Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡